Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Heart Attacks, Cancer and strokes. Preventative approaches -- Ignore unavailable to you. Want to Upgrade?

To: Lane3 who wrote (6319)	8/25/2009 6:31:26 AM
From: Lane3	1 Recommendation Respond to of 39304

Fish Oil Rivals Antidepressants in Clinical Trial from Dr. Jonny Bowden by Dr. Jonny Bowden by Craig Weatherby The results of the largest-ever clinical trial found that omega-3 fish oil may significantly benefit half of all people diagnosed with depression. Specifically, fish oil seemed to help the 50 percent of depression patients who are free from diagnosed anxiety disorders. Fish oil appeared to help these people about as much as the leading class of antidepressant drugs ... that is, selective serotonin re-uptake inhibitors (SSRIs) such as Prozac and Paxil. Participants for the trial were people diagnosed with moderate to severe unipolar (i.e., not bipolar) major depression who were unable to tolerate antidepressants, who refused them despite a physician's recommendation, or who were not helped by the drugs. More than 430 patients with an episode of major depression were assigned to take either with omega-3 EPA from fish oil (1,050mg per day) for two months or an identical-looking placebo pill masked with fish odor. Fish oil did not perform better than placebo, for the patients diagnosed with anxiety as well as depression. <snip>